INEOS announces mega-investment in port of Antwerp
INEOS plans to build a brand-new propane dehydrogenisation (PDH) plant and an ethane cracker. INEOS has chosen the port of Antwerp as the location for a mega-investment of 3 billion euros representing 400 new jobs.
Almac Group Flows into Continuous Technology
Implementation of continuous flow expertise at its global headquarters in Craigavon, UK, with further plans to introduce flow capacity within Arran Chemical Company (Athlone, Ireland).
Ercros has started up the second expansion of the Vila-seca I chlorine plant
Ercros has started a second expansion capacity of 26,000 t/year at the chlorine and caustic soda production plant of its factory in Vila-seca I
Quarterly update from the ECSPP President, Martin Naundorf
During the meeting in Antwerp a new Executive Committee was elected. Early December the new committee had a meeting in which the new President and two Vice Presidents were chosen.
Muttenz, Switzerland – Commercial-scale production of the high-purity renewable platform chemical, 5-Hydroxymethylfurfural (5-HMF) has started at the Biochem-1 facility operated by AVA Biochem in Muttenz, Switzerland. The Swiss-made 5-HMF is made from renewable feed- stock and Biochem-1 will, in a first phase, produce up to 20 tonnes 5-HMF per year.
AVA Biochem offers a sustainable new material for a wide range of applications and sectors, from chemicals and plastics to food and pharmaceuticals. A subsidiary of AVA-CO2, AVA Biochem’s new, innovative production process for 5-HMF is based on a modified version of the hydrothermal carbonisation (HTC) process. Various levels of purity - up to 99.9% - are available. Commercial-scale quantities are now available for delivery.
In 2010, 5-HMF was identified as one of the top 10 most valuable platform chemicals by the United States Department of Energy. It is intensively being used in the research and development of innovative new materials and products, such as for polymers, resins and additives. On announcing the start of commercial-scale production, AVA Biochem’s CEO Jan Vyskocil said, “AVA Biochem's breakthrough HTC technology is opening new markets for renewable 5-HMF. I am convinced that this will push us to the forefront of the bio-based chemical industry.”